Syndax Pharmaceuticals, Inc. (SNDX)
Syndax Pharmaceuticals Market Cap : 1.784B for Feb. 24, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 4.160B |
| Alnylam Pharmaceuticals, Inc. | 44.14B |
| Savara, Inc. | 1.148B |
| BioMarin Pharmaceutical, Inc. | 12.03B |
| Imunon, Inc. | 6.663M |
Market Cap Related Metrics
| PS Ratio | 15.87 |
| Price to Book Value | 15.46 |
| Price | 20.53 |
| Earnings Yield | -17.61% |